Biomarkers are increasingly used alongside histological techniques to diagnose and monitor renal toxicity. Biomarkers such as serum creatinine, blood urea nitrogen (BUN), and emerging urinary markers provide non-invasive means to assess kidney function and detect early signs of toxicity. Histological analysis can validate these findings by providing direct visual evidence of renal damage.
